Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00691015 · OUTCOME

Time to Engraftment (i.e., Absolute Neutrophil Recovery [ANC > 500/mm³] )

Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplant · Source last updated 2017-06-28

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
MEDIAN
Unit
Days
Interval / dispersion
Full Range
Time frame
post transplant, up to 4 weeks

Analysis population: All participants

Groups in this outcome

All Participants

All regimens were analyzed together.

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
All Participants47

Reported measurements

Source class 1
Values in Days · Interval/dispersion: Full Range
GroupValueSpreadLowerUpperComment
All Participants11Not reported915Not reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        lower Limit
        9
        upper Limit
        15
        value
        11
denoms
  1. counts
    1. group Id
      OG000
      value
      47
    units
    Participants
dispersion Type
Full Range
groups
  1. description
    All regimens were analyzed together.
    id
    OG000
    title
    All Participants
param Type
MEDIAN
population Description
All participants
reporting Status
POSTED
time Frame
post transplant, up to 4 weeks
title
Time to Engraftment (i.e., Absolute Neutrophil Recovery [ANC > 500/mm³] )
type
SECONDARY
unit Of Measure
Days

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice